{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04067336",
            "orgStudyIdInfo": {
                "id": "KO-MEN-001"
            },
            "organization": {
                "fullName": "Kura Oncology, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia",
            "officialTitle": "A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "first-in-human-study-of-ziftomenib-in-relapsed-or-refractory-acute-myeloid-leukemia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": true,
                "nctId": "NCT05738538",
                "statusForNctId": "AVAILABLE"
            },
            "startDateStruct": {
                "date": "2019-09-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-06-25",
            "studyFirstSubmitQcDate": "2019-08-22",
            "studyFirstPostDateStruct": {
                "date": "2019-08-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Kura Oncology, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess ziftomenib, a menin-MLL(KMT2A) inhibitor, in patients with relapsed or refractory acute myeloid leukemia (AML) as part of Phase 1. In Phase 2, assessment of ziftomenib will continue in patients with NPM1-m AML.",
            "detailedDescription": "This Phase 1/2, first-in-human (FIH), open-label, dose-escalation and dose-validation/expansion study will assess ziftomenib, a menin-MLL(KMT2A) inhibitor, in patients with relapsed or refractory acute myeloid leukemia (AML).\n\nThe dose-escalation part of the study (Phase 1a) will determine the maximal tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D).\n\nThe dose-validation/expansion part of the study (Phase 1b) will determine the safety, tolerability, and minimal biologically effective dose of ziftomenib in dosing cohorts which have demonstrated early biological activity and have been determined to be safe in the dose-escalation phase.\n\nThe Phase 2 portion of the study will determine the safety, tolerability, and anti-leukemia activity of ziftomenib in patients with NPM1-m AML."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Malignant Neoplasm",
                "Acute Myeloid Leukemia",
                "Mixed Lineage Leukemia",
                "Mixed Lineage Acute Leukemia",
                "Acute Leukemia of Ambiguous Lineage",
                "Mixed Phenotype Acute Leukemia"
            ],
            "keywords": [
                "AML",
                "Hematological malignancy",
                "KMT2A",
                "NPM1",
                "Menin",
                "MLLr",
                "Leukemia",
                "Acute Leukemia"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 199,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1a - Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Ziftomenib"
                    ]
                },
                {
                    "label": "Phase 1b - Dose-Validation Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "Cohort 1: KMT2A-r / NPM1-m patients will receive a dose previously studied in Phase 1a\n\nCohort 2: KMT2A-r / NPM1-m patients will receive a dose previously studied in Phase 1a",
                    "interventionNames": [
                        "Drug: Ziftomenib"
                    ]
                },
                {
                    "label": "Phase 2",
                    "type": "EXPERIMENTAL",
                    "description": "NPM1-m patients will receive the recommended phase 2 dose determined in Phase 1",
                    "interventionNames": [
                        "Drug: Ziftomenib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ziftomenib",
                    "description": "Oral administration",
                    "armGroupLabels": [
                        "Phase 1a - Dose Escalation",
                        "Phase 1b - Dose-Validation Expansion",
                        "Phase 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1a: Maximal tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D)",
                    "description": "MTD is defined as the highest dose that is not expected to cause dose limiting toxicity (DLT) in more than 20% of patients.",
                    "timeFrame": "Dose Limiting Toxicities (DLTs) will be evaluated during the first 28 days (1 cycle)"
                },
                {
                    "measure": "Phase 1b: Number of patients that experience Adverse Events (AEs) and Serious Adverse Events (SAEs).",
                    "description": "Assessed by NCI-CTCAE v5.0",
                    "timeFrame": "During treatment and up to approximately 28 days after treatment discontinuation, or until immediately before the initiation of another anticancer therapy, whichever occurs first."
                },
                {
                    "measure": "Phase 1b: Minimal biologically effective dose",
                    "description": "Minimal biologically effective dose in dosing cohorts which have demonstrated biological activity and have been determined to be safe as a part of Part 1a",
                    "timeFrame": "Up to 12 months following end of treatment"
                },
                {
                    "measure": "Phase 2: Evidence of anti-leukemia activity",
                    "description": "Anti-leukemia activity is assessed by the CR (CR+CRh) rate",
                    "timeFrame": "12 months following end of treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Phase 1a: Number of patients that experience Adverse Events (AEs) and Serious Adverse Events (SAEs).",
                    "description": "Assessed by NCI-CTCAE v5.0",
                    "timeFrame": "During treatment and up to approximately 28 days after treatment discontinuation, or until immediately before the initiation of another anticancer therapy, whichever occurs first."
                },
                {
                    "measure": "Phase 1a: Tmax",
                    "description": "Time to observed maximum plasma concentration of ziftomenib and/or its metabolites",
                    "timeFrame": "Cycle 1 and Cycle 2. Each cycle is 28 days."
                },
                {
                    "measure": "Phase 1a: AUC(0-last)",
                    "description": "Area under the plasma concentration-time curve from time 0 to time of last measurable concentration of ziftomenib and/or its metabolites",
                    "timeFrame": "Cycle 1 and Cycle 2. Each cycle is 28 days."
                },
                {
                    "measure": "Phase 1a: Cmax",
                    "description": "Maximum plasma concentration of ziftomenib and/or its metabolites",
                    "timeFrame": "Cycle 1 and Cycle 2. Each cycle is 28 days."
                },
                {
                    "measure": "Phases 1a, 1b, and 2: Composite definition of complete remission (CR) and complete remission with partial hematologic recovery (CRh)",
                    "description": "To assess the CR (CR+CRh) rate",
                    "timeFrame": "Up to 12 months following discontinuation of treatment"
                },
                {
                    "measure": "Phases 1a, 1b, and 2: Complete response (CR) with and without minimal residual disease (MRD)",
                    "description": "To assess the CR rate with and without MRD",
                    "timeFrame": "Up to 12 months following discontinuation of treatment"
                },
                {
                    "measure": "Phases 1a, 1b, and 2: Duration of remission (DOR)",
                    "description": "To assess the DOR",
                    "timeFrame": "Up to 12 months following discontinuation of treatment"
                },
                {
                    "measure": "Phases 1a, 1b, and 2: Transfusion independence (TI)",
                    "description": "To assess transfusion independence",
                    "timeFrame": "Up to 12 months following discontinuation of treatment"
                },
                {
                    "measure": "Phases 1a, 1b, and 2: Event-free survival (EFS)",
                    "description": "To assess event-free survival",
                    "timeFrame": "Up to 12 months following discontinuation of treatment"
                },
                {
                    "measure": "Phases 1a, 1b, and 2: Overall survival",
                    "description": "To assess overall survival",
                    "timeFrame": "Up to 12 months following discontinuation of treatment"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\nPatients with refractory or relapsed AML defined as the reappearance of \u2265 5% blasts in the bone marrow and who have also failed or are ineligible for any approved standard of care therapies, including HSCT.\n\n1. Phase 1b:\n\n   1. Patients with a documented lysine\\[K\\]-specific methyltransferase 2-rearrangement (KMT2A-r), or\n   2. Patients with a documented nucleophosmin 1 mutation (NPM1-m)\n2. Phase 2:\n\n   a. Patients with a documented nucleophosmin 1 mutation (NPM1-m)\n3. \u2265 18 years of age.\n4. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2, and a life expectancy of at least 2 months.\n5. Adequate liver and kidney function according to protocol requirements.\n6. Peripheral white blood cell (WBC) counts \u2264 30,000/\u03bcL. Patients may receive hydroxyurea to control and maintain white blood cell count prior to enrollment.\n7. Women of childbearing potential must be willing to use a highly effective method of contraception throughout the study and for at least 180 days after the last dose of study treatment.\n8. Males with female partners of childbearing potential must agree to use a highly effective method of contraception throughout the study and for at least 90 days after the last dose of study treatment.\n\nKey Exclusion Criteria:\n\n1. Diagnosis of acute promyelocytic leukemia.\n2. Diagnosis of chronic myelogenous leukemia in blast crisis.\n3. Donor lymphocyte infusion \\< 30 days prior to study entry.\n4. Clinically active central nervous system (CNS) leukemia.\n5. Undergone HSCT and have not had adequate hematologic recovery.\n6. Receiving immunosuppressive therapy post HSCT within 2 weeks of Cycle 1 Day 1.\n7. Grade \u2265 2 active graft-versus-host disease (GVHD), moderate or severe limited chronic GVHD, or extensive chronic GVHD of any severity.\n8. Received chemotherapy immunotherapy, radiotherapy, or any ancillary therapy that is considered to be investigational (i.e., used for non-approved indications(s) and in the context of a research investigation) \\< 14 days prior to the first dose of ziftomenib or within 5 drug half-lives prior to the first dose of study drug.\n9. Not recovered to \\< Grade 2 (National Cancer Institute Common Terminology Criteria for Adverse Events v5.0) from all acute toxicities or deemed back to a stable baseline.\n10. Treatment with concomitant drugs that are strong inhibitors or inducers of cytochrome P450-isozyme 3A4 (CYP3A4) with the exception of antibiotics, antifungals, and antivirals that are used as standard of care or to prevent or treat infections and other such drugs that are considered absolutely essential for the care of the patient.\n11. Detectable viral load for human immunodeficiency virus, hepatitis C, or hepatitis B surface antigen indicative of active infection. Patients with controlled disease will not be excluded from study enrollment.\n12. Pre-existing disorder predisposing the patient to a serious or life-threatening infection (e.g. cystic fibrosis, congenital or acquired immunodeficiency, bleeding disorder, or cytopenias not related to AML).\n13. Active uncontrolled acute or chronic systemic fungal, bacterial, viral, or other infection.\n14. Significant cardiovascular disease including unstable angina pectoris, uncontrolled hypertension or arrhythmia, history of cerebrovascular accident including transient ischemic attack within the past 6 months, congestive heart failure (NYHA Class III or IV) related to primary cardiac disease, ischemic or severe valvular heart disease, or a myocardial infarction within 6 months prior to the first dose of study treatment.\n15. Mean QTcF \\>480 ms on triplicate ECG.\n16. Major surgery within 4 weeks prior to the first dose of study treatment.\n17. Women who are pregnant or lactating. All female patients with reproductive potential must have a negative serum pregnancy test within 72 hours prior to starting treatment.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Operations",
                    "role": "CONTACT",
                    "phone": "858 500 8800",
                    "email": "KO-MEN-001@kuraoncology.com"
                }
            ],
            "locations": [
                {
                    "facility": "Banner MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Gilbert",
                    "state": "Arizona",
                    "zip": "85234",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "BMDACCResearch@bannerhealth.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.35283,
                        "lon": -111.78903
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85054",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joshua Sandolo",
                            "role": "CONTACT",
                            "phone": "480-574-2296",
                            "email": "Sandolo.Joshua@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "University of Southern California",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christine Duran",
                            "role": "CONTACT",
                            "phone": "323-865-0371",
                            "email": "duran_c@med.usc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "UCLA Bowyer Oncology Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bruck Habtemariam",
                            "role": "CONTACT",
                            "email": "BHabtemariam@mednet.ucla.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "507-538-3365"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "Northwestern University",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "jillian.weeks@northwestern.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Indiana University Melvin and Bren Simon Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jill Weisenbach, RN",
                            "role": "CONTACT",
                            "phone": "317-278-0597",
                            "email": "Jweisenb@iupui.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "University of Maryland Greenebaum Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Larissa Sanglard, MD",
                            "role": "CONTACT",
                            "phone": "410-328-8370",
                            "email": "larissa.sanglard@umm.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christine Connolly",
                            "role": "CONTACT",
                            "email": "CCONNOLLY1@mgh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Michigan Hospitals",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "800-865-1125",
                            "email": "canceranswerline@med.umich.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emily Tolksdorf",
                            "role": "CONTACT",
                            "phone": "313-576-9814",
                            "email": "tolksdoe@karmanos.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cancer Center Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Hackensack University Medical Center - John Theurer Cancer Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lumi Demirovic",
                            "role": "CONTACT",
                            "phone": "551-996-8154",
                            "email": "Ljumnije.demirovic@hmhn.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Roswell Park Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Buffalo",
                    "state": "New York",
                    "zip": "14203",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "askroswell@roswellpark.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.88645,
                        "lon": -78.87837
                    }
                },
                {
                    "facility": "Weill Cornell Medical College - NY Presbyterian Hospital",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tania Curcio",
                            "role": "CONTACT",
                            "phone": "212-746-2571",
                            "email": "tjc9003@med.cornell.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "The Mount Sinai Hospital",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10029",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tina Czaplinska",
                            "role": "CONTACT",
                            "phone": "212-241-3659",
                            "email": "Tina.czaplinska@mssm.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "hematologyresearch@duke.edu",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Oklahoma University Health - Stephenson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73117",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Silas Day",
                            "role": "CONTACT",
                            "email": "Silas-Day@ouhsc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "UPMC Hillman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Felicia Kass",
                            "role": "CONTACT",
                            "email": "kassfe2@upmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "Vanderbilt-Ingram Cancer Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Recruitment and Eligibility Office",
                            "role": "CONTACT",
                            "phone": "800-811-8480",
                            "email": "cip@vumc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Harold C. Simmons Comprehensive Cancer Center - UT Southwestern Medical Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yasmeen Akhtar, MBBS,MS,CCRP",
                            "role": "CONTACT",
                            "phone": "214-648-5130",
                            "email": "Yasmeen.Akhtar@UTSouthwestern.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rachel Abramowicz",
                            "role": "CONTACT",
                            "email": "rrabramo@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Research Center",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "UZ Brussel",
                    "status": "RECRUITING",
                    "city": "Jette",
                    "zip": "1090",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 50.87309,
                        "lon": 4.33419
                    }
                },
                {
                    "facility": "AZ Delta - Campus Rumbeke",
                    "status": "RECRUITING",
                    "city": "Roeselare",
                    "zip": "8800",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 50.94653,
                        "lon": 3.12269
                    }
                },
                {
                    "facility": "Queen Elizabeth II Health Sciences Centre",
                    "status": "RECRUITING",
                    "city": "Halifax",
                    "state": "Nova Scotia",
                    "zip": "B3H 1V7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 44.64533,
                        "lon": -63.57239
                    }
                },
                {
                    "facility": "Hopital Maisonneuve-Rosemont",
                    "status": "RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H1T 2M4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Hopital de l'Enfant-Jesus - Centre Integre en Cancerologie du CHU de Quebec - Universite Laval",
                    "status": "RECRUITING",
                    "city": "Qu\u00e9bec",
                    "state": "Quebec",
                    "zip": "G1J 1Z4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "CHU de Quebec - Universite Laval, Hopital de l'Enfant - Jesus",
                    "status": "RECRUITING",
                    "city": "Qu\u00e9bec",
                    "state": "Quebec",
                    "zip": "G1S 4L8",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "CHU de Lille",
                    "status": "RECRUITING",
                    "city": "Lille",
                    "zip": "59037",
                    "country": "France",
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "CHU de Nantes",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "zip": "44093",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Hopital Saint Louis",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75475",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Magendie Hopital Haut-Leveque",
                    "status": "RECRUITING",
                    "city": "Pessac",
                    "zip": "33600",
                    "country": "France",
                    "geoPoint": {
                        "lat": 44.81011,
                        "lon": -0.64129
                    }
                },
                {
                    "facility": "Centre Hospitalier Lyon Sud",
                    "status": "RECRUITING",
                    "city": "Pierre-B\u00e9nite",
                    "zip": "69310",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "Institut Gustave Roussy",
                    "status": "RECRUITING",
                    "city": "Villejuif",
                    "zip": "94800",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                },
                {
                    "facility": "Charit\u00e8-Campus Benjamin Franklin",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "12203",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "University Medicine Greifswald",
                    "status": "RECRUITING",
                    "city": "Greifswald",
                    "zip": "17475",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 54.09311,
                        "lon": 13.38786
                    }
                },
                {
                    "facility": "Medizinische Hochsschule Hannover",
                    "status": "RECRUITING",
                    "city": "Hannover",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.37052,
                        "lon": 9.73322
                    }
                },
                {
                    "facility": "Johannes Gutenberg - University Mainz",
                    "status": "RECRUITING",
                    "city": "Mainz",
                    "zip": "55131",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.98419,
                        "lon": 8.2791
                    }
                },
                {
                    "facility": "Institute of Hematology and Medical Oncology \"L. and A. Seragnoli\"",
                    "status": "RECRUITING",
                    "city": "Bologna",
                    "zip": "40138",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.49381,
                        "lon": 11.33875
                    }
                },
                {
                    "facility": "IRCCS Istituto Romagnolo per lo Studio dei Tumori \"Dino Amadori\"",
                    "status": "RECRUITING",
                    "city": "Meldola",
                    "zip": "47014",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.12775,
                        "lon": 12.0626
                    }
                },
                {
                    "facility": "UO Ematologia Ospedale di Ravenna",
                    "status": "RECRUITING",
                    "city": "Ravenna",
                    "zip": "48121",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.41344,
                        "lon": 12.20121
                    }
                },
                {
                    "facility": "Institution Fondazione Policlinico Tor Vergata",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Hospital Universitari Vall d'Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Universitat de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28033",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario HM Sanchinarro",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28050",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Central de Asturias",
                    "status": "RECRUITING",
                    "city": "Oviedo",
                    "zip": "33011",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 43.36029,
                        "lon": -5.84476
                    }
                },
                {
                    "facility": "Hospital Universitario Virgen del Rocio",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "zip": "41013",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Hospital Universitari i Politecnic La Fe",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46026",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Beatson West of Scotland Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Glasgow",
                    "zip": "G12 0YN",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 55.86515,
                        "lon": -4.25763
                    }
                },
                {
                    "facility": "St. George's Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "SW17 0QT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34267079",
                    "type": "DERIVED",
                    "citation": "Sasca D, Guezguez B, Kuhn MWM. Next generation epigenetic modulators to target myeloid neoplasms. Curr Opin Hematol. 2021 Sep 1;28(5):356-363. doi: 10.1097/MOH.0000000000000673."
                },
                {
                    "pmid": "33741715",
                    "type": "DERIVED",
                    "citation": "Jimenez JA, Apfelbaum AA, Hawkins AG, Svoboda LK, Kumar A, Ruiz RO, Garcia AX, Haarer E, Nwosu ZC, Bradin J, Purohit T, Chen D, Cierpicki T, Grembecka J, Lyssiotis CA, Lawlor ER. EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma. Mol Cancer Res. 2021 Jul;19(7):1182-1195. doi: 10.1158/1541-7786.MCR-20-0679. Epub 2021 Mar 19."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000015470",
                    "term": "Leukemia, Myeloid, Acute"
                },
                {
                    "id": "D000015456",
                    "term": "Leukemia, Biphenotypic, Acute"
                },
                {
                    "id": "D000000208",
                    "term": "Acute Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21314",
                    "name": "Hematologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18118",
                    "name": "Leukemia, Biphenotypic, Acute",
                    "asFound": "Mixed Lineage Acute Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3564",
                    "name": "Acute Disease",
                    "asFound": "Acute Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T174",
                    "name": "Acute Leukemia of Ambiguous Lineage",
                    "asFound": "Acute Leukemia of Ambiguous Lineage",
                    "relevance": "HIGH"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "asFound": "Acute",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}